This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramos, M. M.
Right arrow Articles by Hjelle, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramos, M. M.
Right arrow Articles by Hjelle, B.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 108 No. 2 August 2001, p. e27

ELECTRONIC ARTICLE:
Infection With Sin Nombre Hantavirus: Clinical Presentation and Outcome in Children and Adolescents

Received Jun 28, 2000; accepted Apr 4, 2001.

Mary M. Ramos*, Gary D. Overturf*, Dagger , Mark R. Crowley*, Robert B. Rosenberg§, and Brian HjelleDagger

From the * Department of Pediatrics and Dagger  Department of Pathology and Tricore Reference Laboratory, University of New Mexico Health Sciences Center, Albuquerque, New Mexico; and § Department of Pediatrics, Texas Tech University Health Sciences Center, Lubbock, Texas.

Objective.  Sin Nombre hantavirus (SNV) is the leading causative agent of hantavirus cardiopulmonary syndrome (HCPS) in the United States and Canada. Relatively few cases of HCPS have involved children. This report describes the clinical characteristics of a series of pediatric cases of SNV infection in the United States and Canada from 1993 through March 2000.

Methods.  We analyzed clinical and laboratory data on 13 patients who were <= 16 years old with SNV infection from 1993 through March 2000 identified from a database at the University of New Mexico.

Results.  The patients ranged from 10 to 16 years of age, with a median of 14. Fifty-four percent were female. Fifty-four percent were Native American. The most common prodromal symptoms were fever, headache, and cough or dyspnea (100%); nausea or vomiting (90%); and myalgia (80%). The most common physical findings at admission were tachypnea (67%) and fever (56%); hypotension was seen in 33% of patients. On admission, all patients manifested thrombocytopenia (median platelet count: 67 000/mm3) and elevated lactate dehydrogenase (median level: 1243 IU/L), and >85% of patients had elevated levels of serum aspartate aminotransferase, alanine aminotransferase, and hypoalbuminemia. Leukocytosis and hemoconcentration were seen in less than one third of patients at admission. HCPS developed in 12 of the 13 patients (92%), and 4 of those 12 died (33% case-fatality ratio). The majority of HCPS patients (8 of 12 [67%]) were critically ill and required mechanical ventilation. Extracorporeal membrane oxygenation was used in 2 patients, 1 of whom survived. An elevated prothrombin time (>= 14 seconds) at admission was predictive of mortality.

Conclusions.  Infection with SNV in children and adolescents causes HCPS with a clinical course and mortality rate similar to that described in adults. We believe that early recognition of HCPS in children and adolescents and appropriate referral to tertiary care centers that are experienced with HCPS are important in reducing mortality.  Key words:  hantavirus, children, adolescents, extracorporeal membrane oxygenation.